On ECHEMI
Home > Drugs > Taishan City Xinning Pharmaceutical Co., Ltd.
Taishan City Xinning Pharmaceutical Co., Ltd.
  • Founded in:

    2005-06-24
  • Country:

    China China
  • Address:

    No. 223, Renxiao Road, Taicheng Town, Taishan City
  • Tax NO.:

    91440781776913130X
  • Registered Funds:

    100 million yuan
  • Email:

Related Drugs
hydrochloric acid
Name Description Content CAS NO. Registered Holders
Hydrochloric acid

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Propylthiouracil Tablets
The main component of this product is propylthiouracil. Its chemical name is 6-propyl-2-thio-2,3-dihydro-4 (1H) pyrimidinone. Molecular formula: C7H10N2OS Molecular weight: 170.24
Name Description Content CAS NO. Registered Holders
Propylthiouracil

Antithyroid drugs. Its mechanism of action is to inhibit peroxidase in the thyroid gland, thereby preventing the iodination of tyrosine and the condensation of iodinated tyrosine in the thyroid gland, thereby inhibiting the synthesis of thyroxine. At the same time, it inhibits the conversion of T4 to T3 in peripheral tissues, causing the content of more active T3 in serum to decrease rapidly.

More

Antithyroid drugs. Its mechanism of action is to inhibit peroxidase in the thyroid gland, thereby preventing the iodination of tyrosine and the condensation of iodinated tyrosine in the thyroid gland, thereby inhibiting the synthesis of thyroxine. At the same time, it inhibits the conversion of T4 to T3 in peripheral tissues, causing the content of more active T3 in serum to decrease rapidly.

51-52-5 11
Ferrous Sulfate Tablets
Ferrous Sulfate
Name Description Content CAS NO. Registered Holders
FERROUS SULFATE

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

More

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

7720-78-7 4
Oxytetracycline
Name Description Content CAS NO. Registered Holders
Oxytetracycline

Extract from the above information

More

Extract from the above information

79-57-2 34
Roxithromycin
Roxithromycin
Name Description Content CAS NO. Registered Holders
Roxithromycin

80214-83-1 28
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.